CA Stock MarketDetailed Quotes
TELO Telo Genomics Corp
- 0.120
- 0.0000.00%
15min DelayMarket Closed Nov 29 16:00 ET
8.95MMarket Cap-3000P/E (TTM)
0.120High0.120Low10.00KVolume0.120Open0.120Pre Close1.20KTurnover0.23052wk High0.01%Turnover Ratio74.56MShares0.10552wk Low-0.04EPS TTM8.48MFloat Cap6.500Historical HighLossP/E (Static)70.66MShs Float0.050Historical Low-0.04EPS LYR0.00%Amplitude--Dividend TTM15.00P/B1Lot Size--Div YieldTTM
Telo Genomics Corp Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 6.48%-2.46M | 24.97%-504.38K | 12.49%-581.77K | 9.89%-682.63K | -29.06%-690.38K | -46.49%-2.63M | -50.26%-672.23K | -50.90%-664.84K | -30.11%-757.56K | -64.70%-534.93K |
| Net income from continuing operations | 3.82%-2.71M | 29.90%-599.25K | 14.75%-606.06K | -30.65%-835.15K | -9.21%-672.55K | -33.66%-2.82M | -30.87%-854.87K | -38.04%-710.89K | -37.97%-639.21K | -28.58%-615.81K |
| Operating gains losses | ---8.4K | --0 | ---10K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 19.39%39.54K | -13.41%8.81K | 9.61%9.87K | 35.54%10.54K | 67.55%10.31K | -41.86%33.11K | -6.43%10.18K | -35.60%9K | -51.73%7.78K | -61.50%6.15K |
| Remuneration paid in stock | -59.69%64.56K | -191.95%-38.26K | --0 | 404.87%60.75K | -34.30%42.07K | 5.79%160.17K | 68.03%41.61K | -49.95%42.49K | -17.13%12.03K | 135.16%64.03K |
| Change In working capital | 7,743.98%158.15K | -4.99%124.32K | 548.38%24.42K | 157.63%79.62K | -757.21%-70.22K | -101.93%-2.07K | -23.13%130.86K | 77.75%-5.45K | 7.63%-138.16K | -90.37%10.68K |
| -Change in receivables | 226.09%32.51K | 98.15%-515 | 634.27%39.3K | -499.84%-7.62K | -82.12%1.35K | -143.89%-25.79K | -241.40%-27.88K | -126.34%-7.36K | 120.09%1.91K | -85.42%7.55K |
| -Change in prepaid assets | 128.16%14.17K | -154.12%-9.95K | 181.67%16.93K | 82.49%-12.97K | -22.65%20.16K | -79.29%-50.33K | 129.90%18.39K | 32.21%-20.73K | -495.96%-74.05K | 275.86%26.07K |
| -Change in payables and accrued expense | 50.54%111.47K | -3.96%134.79K | -240.51%-31.81K | 251.81%100.21K | -300.07%-91.73K | -3.10%74.05K | -1.52%140.35K | 142.34%22.64K | 48.29%-66.01K | -143.90%-22.93K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 6.48%-2.46M | 24.97%-504.38K | 12.49%-581.77K | 9.89%-682.63K | -29.06%-690.38K | -46.49%-2.63M | -50.26%-672.23K | -50.90%-664.84K | -30.11%-757.56K | -64.70%-534.93K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 92.59%-5.12K | -129.44%-2.32K | 0 | 0 | 91.33%-2.8K | -174.13%-69.06K | 95.53%-1.01K | -27.99K | -195.05%-7.75K | -32.31K |
| Net PPE purchase and sale | 92.59%-5.12K | -129.44%-2.32K | --0 | --0 | 91.33%-2.8K | -174.13%-69.06K | 95.53%-1.01K | ---27.99K | -195.05%-7.75K | ---32.31K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 92.59%-5.12K | -129.44%-2.32K | --0 | --0 | 91.33%-2.8K | -174.13%-69.06K | 95.53%-1.01K | ---27.99K | -195.05%-7.75K | ---32.31K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -78.09%587.05K | -76.64%611.83K | -22.5K | 0 | -2.28K | 205.59%2.68M | 2.62M | 0 | -84.49%60K | 0 |
| Net issuance payments of debt | -200.00%-22.5K | --0 | ---- | ---- | ---- | ---7.5K | ---7.5K | ---- | ---- | ---- |
| Net common stock issuance | -77.06%650K | ---- | ---- | ---- | ---- | 1,353.27%2.83M | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | ---- | ---- | -91.41%60K | --0 | --0 | ---- | ---- |
| Net other financing activities | 80.50%-40.45K | ---38.17K | --0 | --0 | ---2.28K | -1,145.26%-207.47K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -78.09%587.05K | -76.64%611.83K | ---22.5K | --0 | ---2.28K | 205.59%2.68M | --2.62M | --0 | -84.49%60K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -0.73%2.67M | -5.04%690.88K | -8.82%1.3M | -6.96%1.98M | -0.73%2.67M | -25.95%2.69M | -77.00%727.58K | -60.58%1.42M | -44.08%2.13M | -25.95%2.69M |
| Current changes in cash | -9,420.37%-1.88M | -94.60%105.14K | 12.78%-604.27K | 3.22%-682.63K | -22.60%-695.47K | 97.91%-19.72K | 514.03%1.95M | -57.25%-692.83K | -256.20%-705.31K | -443.78%-567.25K |
| End cash Position | -70.22%796.02K | -70.22%796.02K | -5.04%690.88K | -8.82%1.3M | -6.96%1.98M | -0.73%2.67M | -0.73%2.67M | -77.00%727.58K | -60.58%1.42M | -44.08%2.13M |
| Free cash from | 8.68%-2.46M | 24.74%-506.7K | 16.03%-581.77K | 10.80%-682.63K | -22.20%-693.18K | -48.26%-2.7M | -43.26%-673.24K | -57.25%-692.83K | -30.85%-765.31K | -74.65%-567.25K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data